All In MedTech

FDA Clearance Tracker · P930039-S170

CapSureFix Novus MRI SureScan Lead

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 16, 2017 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 16, 2017

Approved

Time to decision

90 days

Received May 18, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P930039-S170
Device name
CapSureFix Novus MRI SureScan Lead
Applicant location
Mounds View, MN
Received
May 18, 2017
Decided
Aug 16, 2017
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P930039

Device type

Device class
Class III

Every decision under product code NVN

FDA's approval statement

As written in FDA's record.

Approval for the Azure SR and DR MRI SureScan Implantable Pulse Generators.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.